Pharma Mar SA (PHMMF)
106.48
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Pharma Mar EPS Diluted (Quarterly) : 0.1033 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oryzon Genomics SA | -0.0185 |
| Grifols SA | 0.1255 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alkermes Plc | -0.40 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.794M |
| Revenue (Quarterly) | 50.19M |
| Total Expenses (Quarterly) | 48.40M |
| Enterprise Value | 1.710B |
| Gross Profit Margin (Quarterly) | 86.61% |
| Profit Margin (Quarterly) | 3.57% |
| Earnings Yield | 4.99% |
| Operating Earnings Yield | 2.69% |
| Normalized Earnings Yield | 4.990 |